Abbott Beats 'Supersized' Investor Suit Over Formula Recall
An Illinois federal judge tossed a proposed securities class action accusing Abbott Laboratories of misleading shareholders about its safety practices ahead of the 2022 recall at its Sturgis, Michigan, infant formula...To view the full article, register now.
Already a subscriber? Click here to view full article